{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:29:39Z","timestamp":1793824179457,"version":"4.6.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/mbc.0000000000000486","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T16:53:24Z","timestamp":1449852804000},"page":"477-480","source":"Crossref","is-referenced-by-count":25,"title":["Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients"],"prefix":"10.1097","volume":"27","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan P.","family":"Culhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling","year":"2012","journal-title":"Br J Haematol"},{"key":"R2-24-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1160\/TH08-06-0353","article-title":"Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices","volume":"101","author":"Moffat","year":"2009","journal-title":"Thromb Haemost"},{"key":"R3-24-20210203","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1309\/AJCP4SPPLG5XVIXF","article-title":"Lupus anticoagulant testing: performance and practices by North American Clinical Laboratories","volume":"134","author":"Dembitzer","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R4-24-20210203","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R5-24-20210203","first-page":"69","article-title":"Clinical utility of the less commonly employed assays for lupus anticoagulation detection: the evidence","volume":"2","author":"Moore","year":"2010","journal-title":"J Coag Dis"},{"key":"R6-24-20210203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jcp.47.6.497","article-title":"The Taipan snake venom time: a new test for lupus anticoagulant","volume":"47","author":"Rooney","year":"1994","journal-title":"J Clin Pathol"},{"key":"R7-24-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mbc.0000061283.28953.39","article-title":"The ecarin time is an improved confirmatory test for the taipan snake venom time in warfarinised patients with lupus anticoagulants","volume":"14","author":"Moore","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R8-24-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1477-9560-5-12","article-title":"Combining Taipan snake venom time\/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients","volume":"5","author":"Moore","year":"2007","journal-title":"Thromb J"},{"key":"R9-24-20210203","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1538-7836.2011.04395.x","article-title":"Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time","volume":"9","author":"van Os","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R10-24-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MBC.0000000000000247","article-title":"Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism","volume":"26","author":"Savino","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-24-20210203","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/jth.12917","article-title":"Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome","volume":"13","author":"Arachchillage","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R12-24-20210203","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0961203315581207","article-title":"Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II\/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE","volume":"24","author":"Cohen","year":"2015","journal-title":"Lupus"},{"key":"R14-24-20210203","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1538-7836.2010.03807.x","article-title":"No more mixing tests required for integrated assay sytems in the laboratory diagnosis of lupus anticoagulants?","volume":"8","author":"Devreese","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R15-24-20210203","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jth.13020","article-title":"Mixing studies in lupus anticoagulant testing are required at least in some type of samples","volume":"13","author":"Devreese","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R16-24-20210203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2015.05.001","article-title":"Direct oral anticoagulants (DOACs) in the laboratory: 2015 review","volume":"136","author":"Adcock","year":"2015","journal-title":"Thromb Res"},{"key":"R17-24-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/PAT.0000000000000252","article-title":"The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples","volume":"47","author":"Bonar","year":"2015","journal-title":"Pathology"},{"key":"R18-24-20210203","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0038-1649701","article-title":"The Textarin\/Ecarin ratio: a confirmatory test for lupus anticoagulants","volume":"70","author":"Triplett","year":"1993","journal-title":"Thromb Haemost"},{"key":"R19-24-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MBC.0b013e3283256037","article-title":"The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist","volume":"20","author":"Parmar","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R20-24-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-3848(99)00096-1","article-title":"Lupus anticoagulant testing with optical end point automation","volume":"96","author":"Luddington","year":"1999","journal-title":"Thromb Res"},{"key":"R21-24-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0049-3848(01)00420-0","article-title":"Dilute prothrombin-time based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin","volume":"105","author":"Liest\u00f8l","year":"2002","journal-title":"Thromb Res"},{"key":"R22-24-20210203","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood-2009-09-244426","article-title":"Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants","volume":"115","author":"Devreese","year":"2010","journal-title":"Blood"},{"key":"R23-24-20210203","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ijlh.12138","article-title":"Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin","volume":"36","author":"Martinuzzo","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"R24-24-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MBC.0000000000000235","article-title":"False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome","volume":"26","author":"G\u00f3ralczyk","year":"2015","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:11:42Z","timestamp":1718237502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201606000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000486","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}